@HypoResolve on Sep 23, 2022
Hypo-RESOLVE consortium @EASD
Various Hypo-RESOLVE members will be featuring at the EASD conference taking place in Stockholm from 19-23 September 2022. Take a look at their contributions in this special Hypo-RESOLVE EASD program...
Paper on Hypo-METRICS study protocol published
The Hypo-RESOLVE consortium is proud to announce that a paper has been published on the Hypo-METRICS study protocol in Diabetic Medicine, namely
Hypo-RESOLVE at #ADA 2022
It’s a wrap: We would like to thank all Hypo-RESOLVE speakers and participants for presenting our research at the scientific sessions at ADA 2022 in New Orleans - we had a blast. We would like to prov...
Hypo-RESOLVE granted 18 months’ project extension
The Hypo-RESOVLE consortium is very pleased to announce that the IMI approved an 18 months’ no-cost extension of the Hypo-RESOLVE action end of April 2022. The project will now terminate in October 20...
Hypo-RESOLVE Virtual Managing Board Meeting
On 15th March 2022, the Hypo-RESOLVE Managing Board gathered online to discuss the action’s progress and plan work for the no-cost project extension, which has been requested with the IMI2 JU to allow...
Podcast Series: Episode 8 on fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project
Making sure that the Hypo-RESOLVE results change the diabetes (research) landscape for the better, is one of our most important goals. For our last episode, we have invited Jens Heisterberg from Novo...